Fluorescence-based assay for detecting compounds for modulating the sodium-calcium exchanger (NCX) in 'forward mode'
Carriers are an up-and-coming target family with enormous potential and offer commercial and scientific possibilities. The sodium/calcium exchanger is an important mechanism for the removal of Ca<2+> from various cells. In the heart, said sodium/calcium exchanger extrudes Ca<2+>, which h...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
27.01.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Carriers are an up-and-coming target family with enormous potential and offer commercial and scientific possibilities. The sodium/calcium exchanger is an important mechanism for the removal of Ca<2+> from various cells. In the heart, said sodium/calcium exchanger extrudes Ca<2+>, which has entered through Ca<2+> channels for the initiation of contractions, while Na<+> enters the heart cell. It is of considerable interest to identify compounds that modulate the activity of the sodium-calcium exchanger. The present invention relates to a fluorescence-based assay for the detection of compounds for modulating the NCX in 'forward mode'. The invention further relates to a parts set comprising cells that express NCX and to the use of said parts set for testing a compound for activity as an agonist or antagonist of NCX. |
---|---|
Bibliography: | Application Number: CN200880008156 |